Europe Phase IV Clinical Trials Market Size to Surpass USD 3.84 Billion by 2030, exhibiting a CAGR of 5.1% Pune, India, Aug. 29, 2023 (GLOBE NEWSWIRE) -- The Global Europe Phase IV Clinical Trials Market Size was valued at USD 2.58 billion in 2022 and is projected to grow from USD 3.84 billion by 2030,...

Drug Companies Spend an Average $13,000 per Patient on Comparative Effectiveness Research in Phase IV RESEARCH TRIANGLE PARK, NC--(Marketwire - Aug 9, 2011) - The cost of running a comparative effectiveness trial is $13,087 per patient during Phase IV, according to a study by Cutting Edge...

Phase IV Clinical Trial Teams Identify Top Challenges for Post-Marketing Studies PHILADELPHIA, PA and RESEARCH TRIANGLE PARK, NC--(Marketwire - Jul 27, 2011) - Phase IV clinical trial managers face several challenges in maximizing the impact of post-marketing studies, but...